GH increases extracellular volume by stimulating sodium reabsorption in the distal nephron and preventing pressure natriuresis

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 4, 2002, Pages 1743-1749

  Johannsson, Gudmundur ^a   Sverrisdóttir, Yrsa Bergmann ^a   Ellegård, Lars ^a   Lundberg, Per Arne ^a   Herlitz, Hans ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; GROWTH HORMONE; NORADRENALIN; PLACEBO; SOMATOMEDIN C;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; EXTRACELLULAR FLUID; EXTRACELLULAR SPACE; FEMALE; GLOMERULUS FILTRATION RATE; GROWTH HORMONE DEFICIENCY; HUMAN; KIDNEY PLASMA FLOW; MALE; NATRIURESIS; NEPHRON; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SODIUM ABSORPTION; SODIUM BALANCE; SODIUM EXCRETION; SODIUM RETENTION;

GLOMERULUS;

EID: 0036273860     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.87.4.8394     Document Type: Article

References (49)

1. Body water and sodium in patients with acromegaly
2. Renal growth hormone receptor gene expression: Relationship to renal insulin-like growth factor system
3. + transport
4. The effects of growth hormone on blood pressure and renin secretion in hypophysectomized rats
5. Stimulation of the renin-angiotensin system by growth hormone in Lewis dwarf rats
6. The antinatriuretic action of biosynthetic human growth hormone in man involves activation of the renin-angiotensin system
7. Blockade of the renin-angiotensin-aldosterone system prevents growth hormone-induced fluid retention in humans
8. Short term growth hormone (GH) treatment of GH-deficient adults increases body sodium and extracellular water, but not blood pressure
9. Expansion of extracellular volume and suppression of a trial natriuretic peptide after growth hormone administration in normal man
10. Insulin-like growth factor I administration induces fluid and sodium retention in healthy adults: Possible involvement of renin and atrial natriuretic factor
11. Decreased plasma and extracellular volume in growth-hormone deficient adults and the acute and prolonged effects of GH administration - A controlled experimental-study
12. Glomerular filtration rate and renal plasma flow in acromegaly
13. Extracellular fluid volume and renal function in pituitary insufficiency and acromegaly
14. Effects of recombinant insulin-like growth factor I on insulin secretion and renal function in normal human subjects
15. Nitric oxide synthesis inhibitor prevents vasodilation by insulin-like growth factor I
16. Body composition, bone metabolism, and heart structure and function in growth hormone(GH)-deficient adults before and after GH replacement therapy at low doses
17. Cardiovascular effects of growth hormone replacement therapy in hypopituitary adults
18. Impaired cardiac performance in GH-deficient adults and its improvement after GH replacement
19. The effects of low-dose recombinant human growth hormone on cardiovascular structure and function in hypopituitary growth hormone-deficient adults
20. Cardiac performance and mass in adults with hypopituitarism: Effects of one year of growth hormone treatment
21. Nitric oxide may mediate the hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency
22. Cardiovascular and renal effects of growth hormone
23. Effects of years of growth hormone treatment on body composition and cardiovascular risk factors in adults with growth hormone deficiency
24. Individualized dose titration of growth hormone (GH) during GH replacement in hypopituitary adults
25. Single- and multi-frequency models for bioelectrical impedance analysis of body water compartments
26. 2O and bromine dilution
27. Deuterium and bromide dilution, and bioimpedance spectrometry independently show that growth hormone-deficient adults have an enlarged extracellular water compartment related to intracellular water
28. Lithium clearance: A new method for determining proximal and distal tubular reabsorption of sodium and water
29. Measurement of angiotensin II in human plasma: Technical modifications and practical experience
30. Measurement of plasma angiotensin II
31. The delayed effect of growth hormone on renal function in humans
32. Beneficial effect of growth hormone treatment in GH-deficient adults
33. Quantitative analysis of the pathophysiology of hypertension
34. Escape from the sodium-retaining effects of mineralcorticoids
35. Atrial natriuretic factor significantly contributes to the mineralocorticoid escape phenomenon. Evidence for a guanylate cyclase-mediated pathway
36. Treatment of adults with growth hormone (GH) deficiency with recombinant human GH
37. Sodium retention with human growth hormone and its subfractions
38. Tubular transport responses to angiotensin
39. Angiotensin II and long-term arterial pressure regulation: The overriding dominance of the kidney
40. Cardiovascular effects of growth hormone treatment in growth-hormone-deficient adults: Stimulation of the renin-aldosterone system
41. Neural control of renal function
42. Neural not tubular dopamine increases glomerular filtration rate in perfused rat kidneys
43. Renal venous outflow and urinary excretion of norepinephrine, epinephrine, and dopamine during graded renal nerve stimulation
44. Hypertension and associated metabolic abnormalities - The role of insulin resistance and the sympathoadrenal system
45. Acromegaly and hypertension: Role of the renin-angiotensin-aldosterone system
46. Plasma renin activity and aldosterone secretion in patients with acromegaly
47. Measurement of cardiac natriuretic hormones (atrial natriuretic peptide, brain natriuretic peptides, and related peptides) in clinical practice: The need for a new generation of immunoassay methods
48. Natriuretic peptides
49. Role of endogenous atrial natriuretic peptide in DOCA-salt hypertensive rats. Effects of a novel nonpeptide antagonist for atrial natriuretic peptide receptor